Profusa Inc

Profusa insider buying signals growth optimism as executives stack shares, driving confidence in its health‑care analytics platform and potential upside for investors.

Profusa’s zero‑cost insider share deal and new Lumee digital‑health platform could spark growth—see how equity, AI analytics, and value‑based care may boost value, not dilute shareholders.